Topotecan Completed Phase 1 Trials for Tumors, Solid Screening

IndicationsStatusPurposePhase
CompletedScreening1
clinicaltrials.gov IdentifierTitleDrugs
NCT00732420Open-label Study of Topotecan and Pazopanib in Advanced Solid Tumors